{"id":447969,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2016-08-26] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T15:43:23.958000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-14.html?wbdisable=false","snippet":"Notice: Prescription Drug List (PDL): Multiple additions August 26, 2016 Our file number: 16-109523-230 The purpose of this Notice of Amendment is to notify the additions of Asunaprevir, Bilastine, Daratumumab, Elotuzumab, Idarucizumab, Ixekizumab, Olaparib, Osimertinib,…","rawSnapshotUrl":"/api/snapshots/raw/447969","browseUrl":"https://replay.healtharchive.ca/job-6/20260103154323/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-14.html?wbdisable=false#ha_snapshot=447969","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}